News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
698,223 Results
Type
Article (39664)
Company Profile (247)
Press Release (658312)
Multimedia
Podcasts (49)
Webinars (12)
Section
Business (204147)
Career Advice (2007)
Deals (35414)
Drug Delivery (95)
Drug Development (81040)
Employer Resources (172)
FDA (16177)
Job Trends (14854)
News (345155)
Policy (32531)
Tag
2024 BioCapital Digital (6)
2024 BioForest Digital (1)
2024 BioForest Standard (1)
2024 BioMidwest Digital (7)
2024 BioMidwest Standard (1)
2024 Bio NC Digital (4)
2024 Bio NC Standard (1)
2024 Biotech Bay Standard (17)
2024 Biotech Beach Digital (8)
2024 Biotech Beach Standard (4)
2024 Genetown Digital (5)
2024 Genetown Standard (8)
2024 Lone Star Bio Digital (4)
2024 Pharm Country Digital (5)
2024 Pharm Country Standard (4)
2025 BioForest Digital (1)
2025 Lone Star Bio Digital (5)
2026 BioCapital Standard (1)
2026 BioMidwest Elite (1)
2026 Bio NC Standard (1)
2026 Biotech Bay Standard (1)
2026 Biotech Beach Elite (1)
2026 Genetown Elite (2)
2026 Genetown Standard (1)
2026 Pharm Country Standard (2)
Academia (2554)
Accelerated approval (5)
Adcomms (20)
Allergies (83)
Alliances (49419)
ALS (88)
Alzheimer's disease (1375)
Antibody-drug conjugate (ADC) (124)
Approvals (16182)
Artificial intelligence (247)
Autoimmune disease (21)
Automation (16)
Bankruptcy (360)
Best Places to Work (11636)
BIOSECURE Act (19)
Biosimilars (105)
Biotechnology (175)
Bladder cancer (77)
Brain cancer (26)
Breast cancer (273)
Cancer (2219)
Cardiovascular disease (172)
Career advice (1675)
Career pathing (30)
CAR-T (145)
Cell therapy (410)
Cervical cancer (19)
Clinical research (65943)
Collaboration (822)
Compensation (522)
Complete response letters (19)
COVID-19 (2585)
CRISPR (38)
C-suite (233)
Cystic fibrosis (100)
Data (2158)
Decentralized trials (2)
Denatured (18)
Depression (41)
Diabetes (264)
Diagnostics (6364)
Digital health (18)
Diversity (8)
Diversity, equity & inclusion (44)
Drug discovery (120)
Drug pricing (98)
Drug shortages (25)
Duchenne muscular dystrophy (93)
Earnings (86466)
Editorial (35)
Employer branding (21)
Employer resources (146)
Events (112208)
Executive appointments (714)
FDA (17401)
Featured Employer (47)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (7)
Funding (744)
Gene editing (101)
Generative AI (19)
Gene therapy (294)
GLP-1 (703)
Government (4411)
Grass and pollen (4)
Guidances (53)
Healthcare (18813)
Huntington's disease (23)
IgA nephropathy (27)
Immunology and inflammation (112)
Indications (29)
Infectious disease (2727)
Inflammatory bowel disease (135)
Inflation Reduction Act (8)
Influenza (51)
Intellectual property (95)
Interviews (311)
IPO (16499)
IRA (40)
Job creations (3630)
Job search strategy (1422)
Kidney cancer (10)
Labor market (38)
Layoffs (463)
Leadership (16)
Legal (7909)
Liver cancer (74)
Lung cancer (317)
Lymphoma (150)
Machine learning (6)
Management (58)
Manufacturing (297)
MASH (65)
Medical device (13368)
Medtech (13373)
Mergers & acquisitions (19445)
Metabolic disorders (671)
Multiple sclerosis (77)
NASH (16)
Neurodegenerative disease (85)
Neuropsychiatric disorders (27)
Neuroscience (1893)
NextGen: Class of 2025 (6512)
Non-profit (4478)
Northern California (2627)
Now hiring (39)
Obesity (358)
Opinion (204)
Ovarian cancer (73)
Pain (83)
Pancreatic cancer (81)
Parkinson's disease (146)
Partnered (21)
Patents (231)
Patient recruitment (106)
Peanut (46)
People (57264)
Pharmaceutical (63)
Pharmacy benefit managers (18)
Phase I (20536)
Phase II (29040)
Phase III (21635)
Pipeline (1153)
Policy (136)
Postmarket research (2563)
Preclinical (8718)
Press Release (64)
Prostate cancer (105)
Psychedelics (30)
Radiopharmaceuticals (245)
Rare diseases (375)
Real estate (5907)
Recruiting (65)
Regulatory (22253)
Reports (46)
Research institute (2320)
Resumes & cover letters (349)
Rett syndrome (4)
RNA editing (4)
RSV (42)
Schizophrenia (66)
Series A (129)
Series B (84)
Service/supplier (11)
Sickle cell disease (52)
Southern California (2259)
Special edition (14)
Spinal muscular atrophy (147)
Sponsored (29)
Startups (3575)
State (2)
Stomach cancer (13)
Supply chain (67)
Tariffs (34)
The Weekly (29)
United States (22655)
Vaccines (681)
Venture capitalists (41)
Weight loss (231)
Women's health (35)
Worklife (15)
Date
Today (214)
Last 7 days (808)
Last 30 days (2498)
Last 365 days (32943)
2025 (10120)
2024 (35218)
2023 (40076)
2022 (51173)
2021 (55710)
2020 (54083)
2019 (46538)
2018 (35018)
2017 (32109)
2016 (31480)
2015 (37552)
2014 (31318)
2013 (26345)
2012 (28570)
2011 (29263)
2010 (27328)
Location
Africa (718)
Alabama (52)
Alaska (7)
Arizona (231)
Arkansas (13)
Asia (37818)
Australia (6181)
California (5992)
Canada (1983)
China (512)
Colorado (263)
Connecticut (270)
Delaware (141)
Europe (81159)
Florida (887)
Georgia (203)
Idaho (57)
Illinois (524)
India (25)
Indiana (306)
Iowa (11)
Japan (157)
Kansas (102)
Kentucky (23)
Louisiana (10)
Maine (62)
Maryland (874)
Massachusetts (4477)
Michigan (216)
Minnesota (386)
Mississippi (2)
Missouri (81)
Montana (27)
Nebraska (25)
Nevada (63)
New Hampshire (62)
New Jersey (1691)
New Mexico (28)
New York (1707)
North Carolina (953)
North Dakota (7)
Northern California (2627)
Ohio (199)
Oklahoma (14)
Oregon (34)
Pennsylvania (1346)
Puerto Rico (11)
Rhode Island (32)
South America (1096)
South Carolina (22)
South Dakota (1)
Southern California (2259)
Tennessee (101)
Texas (885)
Utah (177)
Virginia (142)
Washington D.C. (61)
Washington State (544)
West Virginia (3)
Wisconsin (52)
698,223 Results for "brainchip inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Biotech Beach
BrainChip and Edge Impulse Host Webinar
BrainChip Holdings Ltd (ASX:BRN)(OTCQX:BRCHF)(ADR:BCHPY), and Edge Impulse, the leading development platform for machine learning (ML) on edge devices, are hosting the webinar “Bringing development of BrainChip Akida Neuromorphic models to all using Edge Impulse” August 24 at 11 a.m. PDT.
August 22, 2022
·
3 min read
Business
Chris Stevens, Industry Veteran Joins BrainChip to Lead Worldwide Sales
BrainChip Holdings Ltd, the world’s first commercial producer of neuromorphic AI IP, announced that Chris Stevens has joined as Vice President of Worldwide Sales to lead and expand BrainChip sales.
September 6, 2022
·
2 min read
Business
BrainChip Appoints Duy-Loan Le to its Board of Directors
BrainChip Holdings Ltd, the world’s first commercial producer of ultra-low power neuromorphic AI IP, announces the appointment of Duy-Loan Le to its Board of Directors, as a non-executive director.
October 31, 2022
·
2 min read
Biotech Beach
BrainChip Fortifies Neuromorphic Patent Portfolio with New Awards and IP Acquisition
BrainChip Holdings Ltd, the world’s first commercial producer of ultra-low power neuromorphic AI IP, has extended the breadth and depth of its neuromorphic IP with two new patents granted by the US Patents and Trademarks Office, and the acquisition of previously licensed technology from Toulouse Tech Transfer.
October 12, 2022
·
3 min read
Biotech Beach
Media Alert: BrainChip Presents at Edge AI Summit and AI Hardware Summit
BrainChip Holdings Ltd, the world’s first commercial producer of ultra-low power neuromorphic AI IP, is exhibiting at both Edge AI Summit and AI Hardware Summit, which are being held concurrently at the Santa Clara Marriott in Santa Clara, Calif., September 13-15.
September 8, 2022
·
2 min read
Biotech Beach
Media Alert: BrainChip Demonstrates the Power and Simplicity of Edge AI at Edge Impulse Imagine
Experts from BrainChip Holdings Ltd, the world’s first commercial producer of ultra-low power neuromorphic AI IP, are speaking to audiences at Edge Impulse Imagine about the company’s innovative technology in person at the Computer History Museum in Mountain View, California, and streaming worldwide September 28-30.
September 26, 2022
·
3 min read
Biotech Beach
Media Alert: BrainChip Chief Development Officer Presents at tinyML Neuromorphic Engineering Forum
Anil Mankar, Chief Development Officer at BrainChip Holdings Ltd, the world’s first commercial producer of ultra-low power neuromorphic AI IP, will present “Combining Neuromorphic Design Principles with Modern Machine Learning Algorithms” at tinyML Neuromorphic Engineering Forum at 10:55 a.m. PDT September 27.
September 21, 2022
·
2 min read
Biotech Beach
Media Alert: BrainChip Exhibits its Essential AI Capabilities at the Linley Fall Processor Conference 2022
BrainChip Holdings Ltd, the world’s first commercial producer of ultra-low power neuromorphic AI IP, announced that Chief Development Officer Anil Mankar will present “System-Level Advances in Neuromorphic Performance, Efficiency, Configurability and Scalability” at the Linley Fall Processor Conference 2022 in the Hyatt Regency Hotel in Santa Clara, California, November 1 at 10 a.m. PDT.
October 23, 2022
·
2 min read
Biotech Beach
BrainChip Granted New US Patent for Event-Based Classification
BrainChip Holdings Ltd announced that the US Patents and Trademarks Office has issued BrainChip US Patent 11,227,210 “Event-based Classification of Features in a Reconfigurable and Temporally Coded Convolutional Spiking Neural Network.”
January 18, 2022
·
3 min read
Genetown
Emulate Brain-Chip to Study the Effects of Microgravity on Human Brain Physiology at the International Space Station
Emulate, Inc., a leading provider of next-generation in vitro models, today announced that the Brain-Chip is being sent to the International Space Station U.S. National Laboratory (ISS National Lab) to study the effects of microgravity on human brain physiology as part of the Tissue-Chips in Space initiative sponsored by the National Center for Advancing Translational Sciences (NCATS) at the National Institutes of Health (NIH) and the International Space Station National Lab (ISS-NL).
December 21, 2021
·
3 min read
1 of 69,823
Next